首页>
外国专利>
Use of oncolytic viruses, alone or in combination with a checkpoint inhibitor, for the treatment of cancer
Use of oncolytic viruses, alone or in combination with a checkpoint inhibitor, for the treatment of cancer
展开▼
机译:溶瘤病毒单独或与检查点抑制剂联合用于治疗癌症的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the use of oncolytic viruses (e.g., talimogene laherparepvec), either alone or in combination with immune checkpoint inhibitors (e.g., anti-CTLA-4, anti-PD-1, and anti-PD-L1 compounds such an antibodies) for the treatment of various types of cancer. In addition, the present invention relates to compositions and kits relating to such uses of oncolytic viruses, either alone or in combination with immune checkpoint inhibitors.
展开▼